Tags

Type your tag names separated by a space and hit enter

The Risks of Prescribing Hydroxychloroquine for Treatment of COVID-19-First, Do No Harm.
JAMA Intern Med. 2020 08 01; 180(8):1118-1119.JIM

Authors+Show Affiliations

Department of Medicine, University of California, San Francisco.Department of Medicine, University of California, San Francisco.

Pub Type(s)

Letter
Comment

Language

eng

PubMed ID

32347894

Citation

DeJong, Colette, and Robert M. Wachter. "The Risks of Prescribing Hydroxychloroquine for Treatment of COVID-19-First, Do No Harm." JAMA Internal Medicine, vol. 180, no. 8, 2020, pp. 1118-1119.
DeJong C, Wachter RM. The Risks of Prescribing Hydroxychloroquine for Treatment of COVID-19-First, Do No Harm. JAMA Intern Med. 2020;180(8):1118-1119.
DeJong, C., & Wachter, R. M. (2020). The Risks of Prescribing Hydroxychloroquine for Treatment of COVID-19-First, Do No Harm. JAMA Internal Medicine, 180(8), 1118-1119. https://doi.org/10.1001/jamainternmed.2020.1853
DeJong C, Wachter RM. The Risks of Prescribing Hydroxychloroquine for Treatment of COVID-19-First, Do No Harm. JAMA Intern Med. 2020 08 1;180(8):1118-1119. PubMed PMID: 32347894.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - The Risks of Prescribing Hydroxychloroquine for Treatment of COVID-19-First, Do No Harm. AU - DeJong,Colette, AU - Wachter,Robert M, PY - 2020/4/30/pubmed PY - 2020/9/25/medline PY - 2020/4/30/entrez SP - 1118 EP - 1119 JF - JAMA internal medicine JO - JAMA Intern Med VL - 180 IS - 8 SN - 2168-6114 UR - https://www.unboundmedicine.com/medline/citation/32347894/full_citation L2 - https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/10.1001/jamainternmed.2020.1853 DB - PRIME DP - Unbound Medicine ER -